Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2025

August 7, 2025 4:05 PM

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company"), a biopharmaceutical company focused on developing, manufacturing, and marketing complex generic and proprietary injectable, inhalation, and intranasal products, today reported results for the three months ended June 30, 2025."We are pleased to report strong second-quarter performance, driven primarily by the continued momentum of BAQSIMI®, which has quickly become a...

Read more

Skineez(R) Launches First-Ever Reversible Medical Grade Compression Sock-Made in the USA

August 7, 2025 3:15 PM

Skineez®, a proudly woman-owned wellness apparel brand, has just launched a revolutionary new product: the EZ Comfort™ Reversible Medical Grade Compression Sock. This industry-first innovation combines therapeutic compression with patented skincare technology-and it's made entirely in the USA. Even better? Each pair gives customers two colors for the price of one, delivering unmatched value without compromising on comfort or performance.In a...

Read more

Is Audifort a Scam or the Real Hearing Loss & Tinnitus Solution? Latest 2025 Audifort Reviews Reveal the Truth

August 7, 2025 2:15 PM

If you've been battling persistent ringing in your ears, struggling to follow conversations, or waking up to a dull buzz that never seems to stop, you're not alone. Millions worldwide face the daily frustration of tinnitus and hearing decline, with little to no real solutions from mainstream medicine. While hearing aids and sound-masking devices offer temporary relief, they fail to target the actual root causes, namely neuroinflammation,...

Read more

StratifyMDX Announces Meraki

August 7, 2025 11:00 AM

StratifyMDX is proud to announce Meraki, a revolutionary intelligent health agent designed to reshape how preventive and longitudinal care is delivered. Powered by advanced healthcare guidelines data models integration and adaptive AI, Meraki serves as a continuous learning system that monitors patient data in real time, delivers guideline-aligned insights, and drives personalized clinical action.Rooted in the principles of Medicine 3.0, Meraki...

Read more

enBio Corp Launches ComplianceConnect to Support Healthcare Providers with Accreditation and Regulatory Readiness

August 7, 2025 10:00 AM

enBio Corp is proud to announce the launch of ComplianceConnect, a new division created to help healthcare providers successfully navigate CMS-required audits and maintain continuous regulatory compliance. The division delivers comprehensive support before, during, and after audits conducted by Approved Accrediting Organizations such as The Joint Commission, DNV, HFAP, and CIHQ.With today's healthcare environment placing increasing emphasis on...

Read more

Sinceri Senior Living Adds Six Communities to Expanding Footprint Through Strategic Partnership With National Health Investors

August 7, 2025 9:40 AM

Sinceri Senior Living is proud to announce a strategic expansion through the addition of six senior living communities in partnership with National Health Investors, Inc. (NHI). This marks a significant milestone in Sinceri's continued growth and deepens its relationship with one of the industry's most respected healthcare REITs.Chris Belford, Chief Executive Officer of Sinceri Senior Living, commented on the new partnership:"We are excited to...

Read more

Alta AI Debuts New 3D Perio Index Tool That Drives SRP Acceptance

August 7, 2025 9:00 AM

Alta AI, the leading voice technology provider for dental teams, has announced the launch of its latest innovation: the 3D Interactive Perio Index - a groundbreaking, AI-powered tool that transforms complex periodontal data into a simple, immersive visual experience for patients.Our patient-facing report bridges the gap between clinical diagnosis and understanding, helping to build trust and significantly increase SRP case acceptance."At Alta...

Read more

Bausch Health Announces 2025 Gastrointestinal Health Scholars Program Winners

August 7, 2025 8:00 AM

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals ("Salix"), today announced the recipients of its 2025 Salix Gastrointestinal Health Scholars Program. For the sixth year, Bausch Health is proud to award 10 deserving students living with a GI disease $10,000 each to further their higher education."The overwhelming response to our scholarship program reflects the unwavering drive and...

Read more

Telomir Pharmaceuticals Announces In Vitro Data Showing Telomir-1 Inhibits Key Epigenetic Enzymes Driving Tumor Growth, Autoimmune Disease, Neurodegeneration, and Metabolic Dysfunction

August 7, 2025 8:00 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), a preclinical-stage biotechnology company developing therapies that target the underlying mechanisms of aging and age-related diseases, today announced new preclinical data revealing that Telomir-1 potently inhibits three key histone demethylase enzymes-JMJD3, FBXL10, and FBXL11-that regulate gene expression through epigenetic mechanisms. These enzymes are known to influence tumor progression, immune...

Read more

Smile Digital Health Maintains Key Certifications in Security, Privacy, and Compliance

August 7, 2025 7:00 AM

Smile Digital Health (Smile) is proud to announce the successful maintenance of its certifications for ISO 27001, 27017, and 27018 following the latest surveillance audit. The organization also completed its ISO 13485 internal audit as of June 2025 and achieved SOC 2 Type 2 recertification earlier this year. Smile continues to uphold its certification under the HITRUST Risk-based, 2-year (r2) framework, further solidifying its leadership in...

Read more

Massachusetts Cannabis Contamination Crisis Exposes Federal Negligence While DEA Targets Science, Not Safety

August 7, 2025 5:00 AM

While the Massachusetts Cannabis Control Commission scrambles to contain a major public health scandal involving 544 contaminated marijuana samples, Thomas Prevoznik and the Drug Enforcement Administration (DEA)-the agency that claims to "protect public health and safety from the dangers of drugs"-is nowhere to be found. According to a Public Health and Safety Advisory issued today by the Massachusetts Commission, contaminated and potentially...

Read more

Solo-Dex And Polymedicure Partner To Bring Opioid-Free Acute Pain Management To India And Major Asian Markets

August 6, 2025 8:05 PM

Solo-Dex, Inc., a U.S.-based medical device innovator, and Poly Medicure Ltd. (Polymed), India's leading manufacturer of high-quality medical devices, today announced a strategic manufacturing and supply partnership to bring Solo-Dex's patented, opioid-free regional anesthesia solutions to hospitals across India for the first time.Under this agreement, Polymed will manufacture Solo-Dex's flagship product, the Fascile Continuous Peripheral Nerve...

Read more

Viemed Healthcare Announces Second Quarter 2025 Financial Results

August 6, 2025 5:00 PM

Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, announced today that it has reported its financial results for the three and six months ended June 30, 2025.Operational highlights (all dollar amounts are USD; comparisons are to the period ended June 30, 2024 unless otherwise noted):Net revenues for the quarter...

Read more

Zomedica Announces Second Quarter 2025 Financial Results: Revenue up 14% to $7 Million with 67% Gross Margins and $59 Million in Liquidity to Support Growth

August 6, 2025 4:12 PM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today reported consolidated financial results for the second quarter ended June 30, 2025."We are very pleased with the 14% growth attained in the second quarter as we posted record year-over-year revenue for the 18th straight quarter," said Larry Heaton, Chief...

Read more

NHI Issues Investor Update

August 6, 2025 4:10 PM

National Health Investors, Inc. (NYSE:NHI) has issued the following investor update which can be found at:https://investors.nhireit.com/News/presentations-and-webcasts/default.aspxAbout NHIIncorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary...

Read more

NHI Announces Increase for the Third Quarter 2025 Dividend

August 6, 2025 4:05 PM

National Health Investors, Inc. (NYSE:NHI) announced today that it will pay its third quarter dividend of $0.92 per common share on October 31, 2025, to stockholders of record as of September 30, 2025.About NHIIncorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of...

Read more

Protagonist Reports Second Quarter 2025 Financial Results and Provides Corporate Update

August 6, 2025 4:05 PM

Protagonist Therapeutics (Nasdaq:PTGX) ("Protagonist" or "the Company") today reported financial results for the second quarter ended June 30, 2025, and provided a corporate update."Thus far, 2025 has been a year of breakthrough accomplishments for Protagonist, as we saw rusfertide the topic of the prestigious ASCO Plenary Session in May, the announcement of an oral and injectable triple agonist anti-obesity peptide development candidate in...

Read more

NHI Announces Second Quarter 2025 Results

August 6, 2025 4:05 PM

National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and six months ended June 30, 2025.CEO Comments"We had another great quarter which exceeded our expectations. Given the strong quarterly results and continued good visibility into the second half of the year we are again raising our full year guidance and just announced an increase to our quarterly dividend," said Eric Mendelsohn, NHI's President and CEO."The...

Read more

Joint Genesis Reviews (EXPOSED): Doctor's Analysis Reveals What’s Really Behind This Joint Supplement by BioDynamix

August 6, 2025 3:30 PM

Joint pain is one of the most misunderstood health conditions in America today. It's not just about aging or "wear and tear." In recent years, researchers have begun to uncover the deeper cellular triggers behind joint discomfort, particularly the role of synovial fluid loss, chronic inflammation, and cartilage degeneration driven by microscopic biochemical changes. That's where Joint Genesis by BioDynamix enters the scene.Marketed as a...

Read more

Deep Rx Inc. Appoints Dr. Stanley Marks, Chairman of UPMC Hillman Cancer Center, to Board of Directors to Advance AI-Driven Precision Oncology

August 6, 2025 2:30 PM

Deep Rx Inc., a predictive analytics company advancing AI-driven solutions for precision oncology, is pleased to announce the appointment of Stanley M. Marks, M.D., to its Board of Directors.Dr. Marks brings to Deep Rx decades of leadership in oncology, clinical practice, and translational cancer research. He currently serves as Chairman of UPMC Hillman Cancer Center, Chief of the Division of Hematology-Oncology at UPMC Shadyside, and Clinical...

Read more